Loading clinical trials...
Loading clinical trials...
Evaluation of Text Message Engagement Support of Mindfulness Smartphone
The aim of this study is to assess the usability of two mindfulness smartphone applications (apps) and to evaluate whether text message support can promote engagement with those apps through a 4-week trial comparing support vs. no support.
Part one of this study is to conduct usability testing to understand more about the acceptability and usability of these existing mindfulness apps in a population with depression and anxiety. The goal of usability testing is to identify any usability problems, provide information for future app development, and determine the participant's satisfaction with the apps. Participants will then be randomized to receive either engagement support or no support which will be delivered via text messaging, and will be randomized to use one of the two mindfulness applications for the 4 week period. Specific Aim 2.1 is to evaluate any differences on outcome measures between the two mindfulness apps. Specific Aim 2.2 is to evaluate the differences of outcome measures between text message engagement support versus no support, regardless of the mindfulness app. For Aim 2.1, the investigators predict that all mindfulness apps will be capable of leading to improvements on outcome measures. For Aim 2.2, the investigators predict that the text message engagement support arm will engage more with the mindfulness app and will see greater improvements in outcome measures regardless of the mindfulness app.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Northwester University, Feinberg School of Medicine, Center for Behavioral Intervention Technologies
Chicago, Illinois, United States
Start Date
June 26, 2018
Primary Completion Date
July 1, 2020
Completion Date
August 1, 2020
Last Updated
July 2, 2021
40
ACTUAL participants
Headspace - Meditation and Mindfulness App
BEHAVIORAL
Stop, Breathe, & Think - Meditation and Mindfulness App
BEHAVIORAL
Lead Sponsor
Northwestern University
NCT07360600
NCT06793397
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions